Mitochondrial Fission in Neurodegeneration
Overview
Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders. [@reddy2011]
Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within [neurons](/entities/neurons), and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases. [@mitochondrial2024]
Molecular Machinery of Mitochondrial Fission
- Cytosolic GTPase that translocates to mitochondria during fission
- Forms ring-like structures around mitochondria constricting the membranes[1]
- Recruited by adaptor proteins on the outer mitochondrial membrane
- Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)
...Mitochondrial Fission in Neurodegeneration
Overview
Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders. [@reddy2011]
Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within [neurons](/entities/neurons), and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases. [@mitochondrial2024]
Molecular Machinery of Mitochondrial Fission
- Cytosolic GTPase that translocates to mitochondria during fission
- Forms ring-like structures around mitochondria constricting the membranes[1]
- Recruited by adaptor proteins on the outer mitochondrial membrane
- Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)
Fission Proteins (FIS1, MFF, MiD49, MiD50)
- FIS1: Outer membrane protein serving as [DRP1](/proteins/drp1-protein) receptor
- MFF: Primary DRP1 receptor, essential for peroxisomal and mitochondrial fission
- MiD49/MiD50: Additional DRP1 receptors with tissue-specific expression
- ER tubules wrap around mitochondria at fission sites
- Calcium signaling regulates ER-mitochondria contact formation
- Actin polymerization provides mechanical force for constriction
Mitochondrial Fission in Neurodegenerative Diseases
Alzheimer's Disease
- Increased fission in AD brains correlates with disease severity[2]
- [Aβ](/proteins/amyloid-beta) promotes DRP1 recruitment to mitochondria
- [Tau](/proteins/tau) pathology enhances fission through GSK3β-mediated DRP1 phosphorylation
- Excessive fission leads to mitochondrial fragmentation and energy deficits
Parkinson's Disease
- PINK1/Parkin pathway regulates fission as part of mitophagy[4]
- Mutations in PINK1 or PRKN cause early-onset PD with mitochondrial dysfunction
- DRP1 inhibitors show protective effects in PD models
- Dopaminergic neurons are particularly vulnerable to fission dysregulation
Amyotrophic Lateral Sclerosis
- SOD1 mutations alter mitochondrial dynamics toward fission
- [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology disrupts DRP1 localization
- Increased fission in motor neurons precedes degeneration
- Fission inhibitors protect against ALS-related mitochondrial dysfunction
Huntington's Disease
- Mutant [huntingtin](/proteins/huntingtin) promotes excessive fission
- DRP1 hyperactivity contributes to striatal neuron vulnerability
- Fis1 expression increased in HD models and patients
- Fission blockade reverses mitochondrial deficits in HD models
Therapeutic Implications
DRP1 Inhibitors
- Mdivi-1: Small molecule inhibitor of DRP1 GTPase activity[3]
- P110: Specific DRP1 inhibitor reducing fission without affecting fusion
- Concerns about long-term inhibition due to essential physiological functions
Fis1 Targeting
- Antisense oligonucleotide approaches to reduce Fis1 expression
- Small molecule modulators of Fis1-DRP1 interaction
Combination Strategies
| Approach | Rationale | Status |
|----------|-----------|--------|
| Fission inhibitors + mitophagy enhancers | Coordinate quality control | Preclinical |
| DRP1 inhibitors + metabolic modulators | Restore energy balance | Research |
| Fission + fusion balancing | Optimize dynamics | Experimental |
Assessment Methods
Imaging
- Electron microscopy: Direct visualization of mitochondrial morphology
- Live-cell fluorescence microscopy: Time-lapse analysis of fission events
- Super-resolution microscopy: Nanoscale fission site identification
Biochemical Markers
- DRP1 phosphorylation status (Ser616 vs Ser637)
- FIS1, MFF protein levels
- OPA1 long/short isoform ratio (fusion:fission balance)
Functional Assays
- Mitochondrial network analysis using skeletonization algorithms
- Mitochondrial size distribution quantification
- ATP production and mitochondrial membrane potential measurement
Balance: Fusion vs Fission
The dynamic equilibrium between fusion and fission determines mitochondrial morphology:
Fusion (MFN1/2 + OPA1) ←→ Fission (DRP1 + FIS1/MFF)
Disease-Associated Imbalances
| Disease | Primary Defect | Resulting Morphology |
|---------|---------------|---------------------|
| AD | Fission increase | Fragmented |
| PD | Variable | Fragmented |
| ALS | Fission increase | Fragmented |
| HD | Fission increase | Fragmented |
Therapeutic Goal
Restore optimal dynamics rather than completely blocking fission, as both fusion and fission are essential for mitochondrial health.
Research Gaps
Cell-type specificity: Understanding why specific neurons are vulnerable to fission defects
Temporal targeting: Optimal timing of intervention during disease progression
Delivery methods: Targeting fission modulators to the CNS
Biomarkers: Non-invasive markers of mitochondrial dynamics statusDetailed DRP1 Regulation Mechanisms
Post-Translational Modifications
DRP1 activity is tightly regulated by multiple post-translational modifications that integrate cellular signaling cues:
Phosphorylation:
- Ser616 (activation): Phosphorylated by CDK1/2 during mitosis and by ERK1/2 in response to growth factors[@chen2020]
- Ser637 (inhibition): Phosphorylated by PKA, dephosphorylation by calcineurin activates DRP1[@chen2020]
- Ser40 (inhibition): AMPK-mediated phosphorylation inhibits fission under energy stress
Sumoylation:
- SENP5-mediated sumoylation stabilizes DRP1 on mitochondria
- Promotes fission under stress conditions
- Dysregulated in AD and PD
Ubiquitination:
- VCP/p97-mediated extraction of DRP1 for degradation
- Parkin ubiquitinates DRP1 during mitophagy
- Mitochondrial quality control pathways intersect with fission machinery
Calcium and Calcineurin Signaling
Cytosolic calcium dynamics directly regulate mitochondrial fission:
- Elevated calcium activates calcineurin, which dephosphorylates DRP1 at Ser637
- Activated DRP1 translocates to mitochondria, promoting fission
- ER-mitochondria calcium transfer at MAMs (mitochondria-associated membranes) locally regulates fission
- Calcium dysregulation in neurodegenerative diseases hyperactivates this pathway
AMPK and Energy Sensing
AMPK monitors cellular energy status and regulates fission:
- Energy deficit (low ATP/AMP ratio) activates AMPK
- AMPK phosphorylates DRP1 at multiple sites to promote fission
- Fission enables mitochondrial turnover to restore energy balance
- In AD, impaired AMPK signaling contributes to defective fission[@chen2020]
Structural Basis
ER tubules physically wrap around mitochondria at fission sites[@youle2013]:
- ER-mitochondria contacts span 10-30 nm
- Multiple ER-mitochondria tethering proteins maintain contact
- Calcium signaling at these sites regulates fission machinery recruitment
Molecular Tethers
| Tether | Function | Disease Relevance |
|--------|----------|-------------------|
| VAPB-PTPIP51 | ER-mitochondria link | Disrupted in ALS |
| Mfn2 | Tethering + fusion regulator | Reduced in AD |
| IP3R-GRP75-VDAC | Calcium transfer | Dysregulated in PD |
| BAP31 | ER stress sensor | Activated in neurodegeneration |
Actin Polymerization
Force generation for membrane constriction:
- ER-associated actin polymerization provides mechanical force
- Myosin II recruitment to fission sites
- Formin-mediated actin nucleation at contact sites
- Actin depolymerization blocks fission independent of DRP1
Fission in Neuronal Compartments
Axonal Mitochondrial Fission
Neurons present unique fission requirements[@singh2024]:
- Mitochondria must be sized to traverse axonal diameters
- Fission enables axonal distribution and presynaptic targeting
- Synaptic activity modulates axonal fission rates
- Defects impair synaptic mitochondrial replenishment
Spatial regulation:
- Fission biased toward branch points and varicosities
- Local calcium signals trigger axonal fission
- Synaptic vesicle recycling zones are fission hotspots
Dendritic Fission Patterns
Dendritic mitochondria show compartment-specific fission:
- Spine-targeted mitochondria require fission for entry
- Branch point fission enables dendrite penetration
- Activity-dependent fission shapes spine mitochondrial content
- Dysregulated fission contributes to spine loss in AD
Synaptic Mitochondrial Fission
Presynaptic terminals have specialized fission dynamics:
- High energy demand at terminals requires dynamic fission
- Synaptic activity increases fission frequency
- Fission enables rapid mitochondrial replacement
- Synaptic mitochondrial deficits correlate with neurotransmission failure
Fission-Fusion Balance in Disease
OPA1 (optic atrophy 1) mediates mitochondrial fusion[@kumar2025]:
- Long OPA1 isoforms promote inner membrane fusion
- OPA1 cleavage by OMA1 produces short isoforms
- AD-related stress increases OPA1 cleavage
- Imbalanced OPA1 processing shifts equilibrium toward fission
Disease-Specific Imbalances
| Feature | AD | PD | ALS | HD |
|---------|----|----|-----|-----|
| DRP1 levels | ↑ | ↑/↔ | ↑↑ | ↑↑ |
| OPA1 cleavage | ↑ | ↑ | ↑ | ↑ |
| FIS1 expression | ↑ | ↑ | ↑ | ↑ |
| MFN1/2 levels | ↓ | ↓ | ↓ | ↓/↔ |
| Morphology | Fragmented | Variable | Fragmented | Fragmented |
Therapeutic Implications
Modulating the balance rather than absolute fission:
- Restoring fusion capacity alongside inhibiting excessive fission
- Combination approaches targeting both processes
- Cell-type specific targeting required
- Temporal considerations for intervention timing
Cardiolipin and Membrane Remodeling
Cardiolipin Externalization
Phospholipid dynamics regulate fission[@johnson2025]:
- Cardiolipin normally resides in inner mitochondrial membrane
- Externalization to outer membrane recruits DRP1
- Oxidative stress promotes cardiolipin externalization
- Barth syndrome-related cardiolipin defects impair fission
Membrane Curvature Sensing
Fission proteins sense membrane curvature:
- DRP1 PRE domains bind curved membranes
- INF2-formin complexes generate curvature
- Peripheral proteins shape fission sites
- Curvature defects contribute to disease phenotypes
Novel Therapeutic Approaches
Peptide-Based Inhibitors
- p110 peptide: Blocks DRP1-FIS1 interaction specifically
- DRP1-blocking peptides: Cell-penetrating fission inhibitors
- Mitochondrial-targeted peptides: Localized delivery to CNS
Gene Therapy Strategies
- CRISPR-dCas9 approaches to modulate DRP1 expression
- ASOs targeting DRP1 splice variants
- AAV-mediated delivery of dominant-negative DRP1
- miRNA-based fission regulation
Small Molecule Modulators
| Compound | Target | Status | Notes |
|----------|--------|--------|-------|
| Mdivi-1 | DRP1 GTPase | Preclinical | CNS delivery challenge |
| P110 | DRP1-FIS1 | Preclinical | More selective |
| Dynasore | DRP1 | Research | Broader dynamin inhibition |
| YY1-33 | DRP1 sumoylation | Experimental | Enhances sumoylation |
Combination Strategies
- Fission inhibitors + metabolic enhancers
- Fission modulation + antioxidant treatment
- Fission targeting + tau/α-synuclein clearance
- Fusion-promoting compounds alongside fission inhibitors
Clinical Development Pipeline
Recent progress has accelerated fission-targeted therapy development:
Preclinical Candidates:
- Drp1-ASO: Antisense oligonucleotides reducing DRP1 expression
- mitochondria-p110: Peptide disrupting DRP1-FIS1 binding
- HDL-DRP1: Mitochondria-penetrating DRP1 inhibitor
Translation Challenges:
- CNS delivery remains the primary barrier
- Acute vs chronic dosing considerations
- Selectivity for disease-associated fission vs physiological fission
- Biomarker development for target engagement
Emerging Approaches:
- Brain-penetrant small molecules (e.g., DDR1 inhibitors with DRP1 effects)
- Antibody-based targeting of mitochondrial proteins
- Cell-type specific delivery via AAV capsids
- Nanoparticle-based mitochondrial targeting
Biomarkers for Mitochondrial Fission Status
Blood-Based Markers
- Circulating cell-free mtDNA
- Mitochondrial-derived peptides
- Extracellular vesicle mitochondrial proteins
- Metabolic signatures in plasma
Imaging Biomarkers
- PET probes for mitochondrial function
- MR spectroscopy of mitochondrial metabolites
- Super-resolution microscopy of blood cell mitochondria
- Fluorescence-based fission reporters
Functional Assessments
- Platelet mitochondrial morphology
- Lymphoblast mitochondrial dynamics
- Seahorse assay for bioenergetics
- Mitochondrial stress test outcomes
Quantitative Assessment Methods
Morphological Analysis
Classical Metrics:
- Aspect ratio (length/width)
- Branching index
- Network connectivity
- Fragmentation index
Advanced Techniques:
- Super-resolution STED microscopy
- 3D electron microscopy reconstruction
- Live-cell STED imaging
- Machine learning-based classification
Molecular Markers
| Parameter | Measurement | Disease Relevance |
|-----------|------------|-------------------|
| DRP1 Ser616-P | Western blot/ELISA | Fission activation |
| DRP1 Ser637-P | Western blot/ELISA | Fission inhibition |
| OPA1 long/short ratio | Gel electrophoresis | Fusion capacity |
| FIS1 levels | qPCR/Western | Fission adaptor |
| MFF levels | qPCR/Western | Fission adaptor |
Functional Readouts
- Mitochondrial membrane potential (TMRE, JC-1)
- ATP/ADP ratio (bioluminescence)
- ROS production (MitoSOX)
- Calcium handling (Fura-2)
- Mitochondrial respiration (Seahorse)
Neurodegenerative Disease Context
Alzheimer's Disease Specific Mechanisms
Aβ-DRP1 Interaction:
- Aβ oligomers bind to DRP1 directly
- Aβ promotes DRP1 recruitment to mitochondria
- Aβ-induced ROS activate fission
- Synaptic mitochondria lose fission capacity
Tau-DRP1 Interaction[@manczak2024]:
- Phosphorylated tau binds DRP1
- Tau pathology increases fission frequency
- Synaptic mitochondrial loss precedes tau tangle formation
- DRP1 inhibition protects against Aβ toxicity
Therapeutic Implications:
- Dual targeting of Aβ and mitochondrial fission
- DRP1 inhibitors in early AD prevention
- Fission modulation alongside anti-amyloid therapies
Parkinson's Disease Specific Mechanisms
α-Synuclein-DRP1 Interaction[@zhang2025]:
- α-Synuclein oligomers bind TOM20
- α-Synuclein impairs mitochondrial protein import
- Mitochondrial stress promotes fission
- Fission failure leads to mitophagy impairment
PINK1-Parkin Pathway[@park2024]:
- PINK1 accumulates on damaged mitochondria
- Parkin ubiquitinates outer membrane proteins
- DRP1 is recruited for fission
- Fission enables mitophagy completion
Dopaminergic Neuron Vulnerability:
- High energy demand requires robust mitochondria
- Limited fission capacity in SNc neurons
- Age-related decline affects dopamine neurons first
- Fission modulators may protect vulnerable neurons
Animal Models and Experimental Systems
Genetic Models
| Model | Application | Key Findings |
|-------|-------------|--------------|
| Drp1 flox/flox + CamKII-Cre | Conditional KO | Fission required for neuronal survival |
| Drp1 heterozygous | Partial reduction | Improved mitochondrial morphology in AD models |
| Fis1 overexpression | Fission increase | Accelerated neurodegeneration |
| Mff knockout | Fission loss | Defective mitophagy, accumulation |
Pharmacological Models
- Mdivi-1 treatment: DRP1 inhibition in vivo
- CCCP treatment: Mitochondrial depolarization
- Oligomycin: ATP synthase inhibition
- Rotenone Complex I inhibition
iPSC-Derived Models
- Patient-derived neurons with mitochondrial mutations
- Isogenic controls for variant analysis
- Differentiated dopaminergic neurons from PD patients
- Cortical neurons from AD patients
Cellular Stress Response
Mitochondrial Dynamics in Stress
Oxidative Stress:
- ROS promote DRP1 activation
- Fission increases in response to oxidative damage
- Fragmentation is protective by isolating damaged segments
- Antioxidants reduce fission frequency
Energy Stress:
- AMPK activation promotes fission
- ATP depletion triggers fission for quality control
- Fission enables mitophagy under stress
- Metabolic compromise accelerates fission
Inflammatory Stress:
- Cytokines modulate DRP1 expression
- Microglial activation affects neuronal fission
- NF-κB regulates fission protein transcription
- Inflammasome activation intersects with dynamics
Apoptotic Pathways
- Cytochrome c release requires fission
- Fission enables proper apoptotic execution
- DRP1 cleavage by caspases in apoptosis
- Anti-apoptotic Bcl-2 family proteins regulate fission
Computational Models and Systems Biology
Network Analysis
- Mitochondrial dynamics is governed by ~50 proteins
- Systems biology models predict fission-fusion balance
- Machine learning identifies key regulatory nodes
- Protein-protein interaction networks reveal targets
Modeling Approaches
- Agent-based modeling of fission events
- Quantitative systems pharmacology models
- Single-cell dynamics analysis
- Population-level mitochondrial heterogeneity
Future Directions and Unresolved Questions
Key Knowledge Gaps
Why are specific neurons vulnerable? — SNc dopaminergic neurons have unique fission requirements
Optimal intervention timing — When during disease progression should fission be modulated?
Fission vs. fusion prioritization — Which process is more critical to target?
Cell-type specificity — Can we achieve neuron-specific targeting?
Biomarker development — Non-invasive markers of mitochondrial dynamics statusPromising Research Avenues
- Single-cell mitochondrial dynamics measurement
- In vivo mitochondrial fission imaging
- Brain-penetrant fission modulators
- Gene therapy for fission protein modulation
- Combination approaches with disease-modifying therapies
Recent Research Updates (2024-2026)
Recent advances have clarified the role of mitochondrial fission in neurodegeneration:
- DRP1 phosphorylation and neuronal vulnerability: Studies reveal that specific DRP1 phosphorylation sites (Ser616, Ser637) differentially regulate mitochondrial fission in neurons, with modulation offering therapeutic potential in Alzheimer's and Parkinson's disease[@kim2025].
- Mitochondrial fission in tauopathy: Research demonstrates that hyperphosphorylated tau interacts with DRP1, enhancing fission and contributing to synaptic mitochondrial loss in Alzheimer's disease[@manczak2024].
- [Alpha-synuclein](/proteins/alpha-synuclein) and mitochondrial dynamics: Pathological alpha-synuclein directly binds to mitochondrial proteins, including DRP1 and TOM20, disrupting fission/fusion balance and promoting neuronal death in Parkinson's disease[@zhang2025].
- Therapeutic targeting of fission machinery: Small molecule DRP1 inhibitors (like mdivi-1) have shown neuroprotective effects in preclinical models, though CNS delivery remains challenging[@reddy2024].
- Fission and mitophagy interplay: Recent work reveals that fission is a prerequisite for mitophagy, with defective fission leading to accumulation of dysfunctional mitochondria in neurodegenerative diseases[@liu2025].
- ALS pathogenesis: DRP1-mediated mitochondrial fission is elevated in ALS models and patient tissues, with excessive fission contributing to motor neuron vulnerability[@choi2024].
- Huntington's disease: Mitochondrial dynamics are severely disrupted in HD, with DRP1 hyperactivity contributing to striatal neuron death and fission inhibitors showing protective effects[@iyer2024].
- PINK1-Parkin pathway: New insights into how PINK1 and Parkin coordinate mitochondrial fission as part of the quality control cascade in PD[@park2024].
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Mitochondrial Dynamics Pathway](/mechanisms/mitochondrial-dynamics-pathway)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Mitophagy](/mechanisms/mitophagy)
- [DRP1 Protein](/proteins/drp1-protein)
- [OPA1 Protein](/proteins/opa1-protein)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Youle RJ, Mitochondrial fission and fusion (2013)](https://pubmed.ncbi.nlm.nih.gov/16110319/)
[Reddy PH, Abnormal mitochondrial dynamics, mitochondrial fission and fusion in neurodegenerative diseases (2011)](https://pubmed.ncbi.nlm.nih.gov/21892499/)
[Kane LA, PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity (2014)](https://pubmed.ncbi.nlm.nih.gov/25416956/)
[Van Laar VS, PINK1 deficiency in neurons leads to altered mitochondrial function and morphology (2019)](https://pubmed.ncbi.nlm.nih.gov/31100568/)
[Reddy PH, Inhibitors of mitochondrial fission as a therapeutic strategy for neurodegenerative diseases (2014)](https://pubmed.ncbi.nlm.nih.gov/24635933/)
[Chen W, Mitochondrial dynamics in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32731077/)
[Rodriguez-Rodriguez P, Mitochondrial fission and neurite remodeling (2013)](https://pubmed.ncbi.nlm.nih.gov/24065096/)